Léger O, Dean C J
Institute of Cancer Research, Royal Cancer Hospital, Belmont, Sutton, Surrey, UK.
J Immunol. 1991 Apr 15;146(8):2879-86.
Twelve syngeneic anti-idiotopic mAb (anti-idiotypic/idiotopic antibodies Ab2)) were prepared from CBH/Cbi rats immunized with one of three monoclonal anti-HSN antibodies (Ab1) (11/160, ALN/11/53, or ALN/16/53) specific for the HSN tumor. The sera of the rats used for hybridoma production and all of the monoclonal Ab2 specifically inhibited the binding to HSN of the immunizing Ab1 only. It is concluded that, in this completely syngeneic system, only the private idiotopes associated with the antibody-combining site were immunogenic. Analyses using Western blotting showed that the Ab2 bound to intact Ab1 and to isolated H chains where the intra-strand disulfide bonds remained intact. The Ab2 did not bind to L chains or to fully reduced H chains of the Ab1. It is concluded that the idiotopes expressed on the H chain were conformational. When a panel of 13 monoclonal Ab1 (including the three used for immunization) were tested for reactivity with the Ab2, three reacted specifically with their respective Ab2 and 8 gave no binding suggesting that each Ab1 had a distinct idiotypic specificity despite the fact that all the Ab1 competed with each other for binding to Ag. However, the two remaining Ab1 (ALN/9/94 and ALN/12/17) generated from different tumor-bearing rats, were found to possess the same idiotypic specificity as 11/160. A detailed analysis using seven Ab2 raised against 11/160 showed that while the idiotype of ALN/9/94 and 11/160 were very similar, that of ALN/12/17 showed some clear differences. These three Ab1 have been shown previously to bind a sequential epitope on the HSN Ag in Western blots and it is postulated that the common idiotype of these Ab1 reflects their recognition of a sequential epitope. This may also account for the relatively frequent occurrence in tumor bearer sera of antibodies with this Id.
用三种针对HSN肿瘤的单克隆抗HSN抗体(Ab1)(11/160、ALN/11/53或ALN/16/53)之一免疫CBH/Cbi大鼠,制备了12种同基因抗独特型单克隆抗体(抗独特型/独特型抗体Ab2)。用于杂交瘤生产的大鼠血清以及所有单克隆Ab2仅特异性抑制免疫用Ab1与HSN的结合。得出的结论是,在这个完全同基因的系统中,只有与抗体结合位点相关的私有独特型具有免疫原性。蛋白质印迹分析表明,Ab2与完整的Ab1以及链内二硫键保持完整的分离重链结合。Ab2不与Ab1的轻链或完全还原的重链结合。得出的结论是,重链上表达的独特型是构象性的。当检测一组13种单克隆Ab1(包括用于免疫的三种)与Ab2的反应性时,三种与各自的Ab2发生特异性反应,8种无结合,这表明尽管所有Ab1相互竞争与抗原的结合,但每种Ab1都具有独特的独特型特异性。然而,从不同荷瘤大鼠产生的另外两种Ab1(ALN/9/94和ALN/12/17)被发现与11/160具有相同的独特型特异性。使用针对11/160产生的7种Ab2进行的详细分析表明,虽然ALN/9/94和11/160的独特型非常相似,但ALN/12/17的独特型存在一些明显差异。这三种Ab1先前已在蛋白质印迹中显示与HSN抗原上的一个连续表位结合,据推测这些Ab1的共同独特型反映了它们对一个连续表位的识别。这也可能解释了在荷瘤动物血清中具有这种独特型的抗体相对频繁出现的原因。